Journal of the Neurological Sciences
Volume 206, Issue 2 , Pages 145-152, 15 February 2003

The diagnosis of primary progressive multiple sclerosis

  • Jerry S Wolinsky

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1-713-500-7048; fax: +1-713-500-7041.
  • ,
  • the PROMiSe Study Group

      Affiliations

    • The participating centers and principal investigators of the PROMiSe trial are listed in the acknowledgement.

Department of Neurology, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA

Abstract 

Primary progressive multiple sclerosis (PPMS) is a rather unique form of the more common relapsing inflammatory demyelinative disease. The absence of attacks that typify relapsing forms of MS imposes special challenges for diagnosis, but also provides an opportunity to study the pathogenesis of the more progressive aspects of the disease process in isolation of confounding transient clinical events. In this review, recent advances in diagnostic approaches are considered in relationship to baseline data from a large multinational study designed to better characterize and treat this clinical phenotype. PPMS subjects with cerebral spinal fluid (CSF) findings consistent with intrathecal immunoglobulin production may have a more tissue destructive disease process than those whose CSF lacks evidence of a B-cell immunopathogenic disease component.

Keywords:  Multiple sclerosis, Magnetic resonance imaging (MRI), Cerebral spinal fluid (CSF)

 

PII: S0022-510X(02)00346-5

Journal of the Neurological Sciences
Volume 206, Issue 2 , Pages 145-152, 15 February 2003